Authors

Shannon Westin, MD, MPH, FACOG, the director of Early Drug Development and the Phase I Trials Department, and a professor in the Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, at The University of Texas MD Anderson Cancer Center.

Latest:

Dr Westin on PFS Benefit With DUO-E Regimen Across Histologic and Molecular pMMR Endometrial Cancer Subgroups

Shannon Westin, MD, MPH, FACOG, discusses the efficacy of durvalumab plus chemotherapy and olaparib in pMMR recurrent endometrial cancer.

Shannon N. Westin, MD, MPH, The University of Texas MD Anderson Cancer Center

Latest:

Role of Combination I/O in Advanced Endometrial Cancer (EC)

Shannon N. Westin, MD, MPH, FACOG, discusses the rationale for the use of combination immunotherapy for advanced and recurrent endometrial cancer.

Shannon Puhalla, MD

Latest:

Dr. Puhalla on the Value of Biosimilars in Oncology

Shannon L. Puhalla, MD, assistant professor of medicine, University of Pittsburgh School of Medicine, medical oncologist and hematologist, UPMC Hillman Cancer Center, discusses the value of biosimilars in oncology.

Shantal Ginsberg, RN, NYU Langone Perlmutter Cancer Center

Sharad Ghamande, MD

Latest:

Dr. Ghamande on the AIM2CERV Trial in Cervical Cancer

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.

Sharang Tickoo

Latest:

Medical Marijuana Is a Trojan Horse That Pain Physicians Should Refuse to Accept

Forty-six percent of Americans want marijuana to be legalized. Seventy percent of Americans support the legalization of medical marijuana.

Sharmilan Thanendrarajan, MD

Latest:

Controversy Surrounds Treatment of High-Risk Smoldering Myeloma

A cure concept has not yet been established for asymptomatic and untreated patients with high-risk smoldering myeloma, and debate needs to be initiated surrounding how these patients can be treated sustainably while also taking into account their age, comorbidities, fitness, personal preference, and adverse events of the therapeutic agents.

Sharon Adarlo

Latest:

Tabernero Finds New Paths in Gastrointestinal Treatment Landscape

Josep Tabernero, MD, PHD, MSc, is best known for applying translational research against gastrointestinal tumors, with particular focus on colorectal cancer.

Sharon Francz, BHA

Latest:

Today's Nurse Navigator: Educating and Advocating for Cancer Patients

As both patient advocate and educator, the ONN partners with physicians to help support the cancer patient's journey throughout the course of disease, with the ultimate goal of improving care and outcomes.

Sharon Francz, LPN, BHA

Latest:

Compassion Fatigue: When Caring Takes Its Toll

Every day, oncology nurses provide care to patients who rely on them not only for their physical care, but also emotional and even spiritual care.

Sharon Sa

Latest:

Changes in Prostate Cancer Presentation for Radiation Oncology Care

USPSTF guidelines may have decreased the number of patients presenting with prostate cancer for radiation oncology care, particularly those with low-risk disease, without a short-term increase in higher-risk disease.

Sharon Spencer, MD

Latest:

Dr. Spencer on Radiation Therapy for Patients With Head and Neck Cancer

Sharon Spencer, MD, professor, chief of Medical Services, Ruby Meredith Outstanding Clinician Endowed Chair, University of Alabama at Birmingham School of Medicine, discusses the types of radiation therapy available to patients with head and neck cancer.

Sharyn Lewin, MD, FACS

Latest:

Dr. Lewin on the Impact of COVID-19 on Cancer Care

Sharyn Lewin, MD, FACS, discusses the impact of the coronavirus disease 2019 (COVID-19) on cancer care.

Sharyn N. Lewin, MD, Holy Name Medical Center

Latest:

Ovarian Cancer: Evolving Concepts Around Systemic Therapy

Shayma Kazmi, MD

Latest:

Dr. Kazmi Discusses Olanzapine for Breakthrough CINV

Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting

Shayna L. Showalter, MD

Latest:

UVA Explores Same-Day Brachytherapy With Surgery for Early Breast Cancer

The University of Virginia Cancer Center has developed a new method for delivering radiation therapy along with less invasive surgery in a more precise and personalized manner.

Shayna Sarosiek, MD

Latest:

New Advances in Waldenström Macroglobulinemia

Understanding Waldenström Macroglobulinemia, and genomic profiles influencing clinical presentation and treatment strategies.

Shebli Atrash, MD

Latest:

Dr. Atrash on the Evolution of BCMA-Directed Therapies in Multiple Myeloma

Shebli Atrash, MD, discusses the development and current use of BCMA-targeted antibody-drug conjugates and CAR T-cell therapies for the treatment of patients with multiple myeloma.

Sheetal Kircher, MD

Latest:

Healthcare Reform and the Future of Oncology

The healthcare system in the United States has become increasingly unsustainable.

Sheetal M. Kircher, MD

Latest:

Day in the Life of an Oncology Fellow

When my alarm goes off at 5:30 am, I wake up prepared to play many roles. Juggling family life with 2 young children, caring for my patients as a fellow, and pursuing scholarly activities leaves little free time.